Pure Global AI
NCT06020209Recruiting

CCT for Comprehensive Risk Stratification Following STEMI

Cardiac Computed Tomography for Comprehensive Risk Stratification of Arrhythmic, Atherothrombotic and Heart Failure Events Following Reperfused ST-segment Elevation Myocardial Infarction
University of Turin, ItalyClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Myocardial Infarction
Drug/Device/Intervention
Cardiac Computed Tomography
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
University of Turin, Italy
Location
Messina,Milan,Turin, Italy
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Apr 30, 2026
Enrollment
200 participants
Primary outcome

CCT - diagnostic accuracy,CCT - risk stratification,CCT - Coronary artery disease (CAD) impact of risk stratification

Summary

The CT-STEMI study aims to evaluate a comprehensive cardiac computed tomography (CCT)
 protocol for assessing the risk of heart failure (HF), life-threatening arrhythmias (LTA),
 and atherothrombotic events following ST-elevation myocardial infarction (STEMI). This
 multicenter, prospective study has three main objectives:
 
 1. Comparing the diagnostic accuracy of the comprehensive CCT protocol with cardiac
 magnetic resonance (CMR), considered the non-invasive gold standard.
 
 2. Determining the prognostic value of CCT in assessing myocardial tissue adverse features
 related to STEMI.
 
 3. Evaluating the atherosclerotic burden in patients with post-acute STEMI.
 
 Two hundred patients will undergo both CCT and CMR in the post-acute phase, and their
 follow-up will focus on monitoring HF, LTA, and ischemic events. The CT-STEMI study
 represents the first attempt to assess the potential of CCT in providing a comprehensive risk
 assessment following STEMI in a large contemporary population. The findings of this study
 have the potential to revolutionize post-STEMI risk stratification practices.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedOld myocardial infarctionSubsequent myocardial infarctionObservation for suspected myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06020209
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06020209 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Turin, Italy and is currently Recruiting. The study focuses on Myocardial Infarction. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.